UNICREDIT BANK/CALL/FRESENIUS MEDICAL CARE/80/0.1/18.06.25 Stock

Warrant

DE000HC7JB07

Real-time BOERSE MUENCHEN 03:45:13 2024-05-21 pm EDT
0.009 EUR -25.00% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS MEDICAL CARE/80/0.1/18.06.25
1 month-35.71%
3 months-50.00%
Date Price Change
24-05-21 0.009 -25.00%
24-05-20 0.012 0.00%
24-05-17 0.012 0.00%
24-05-16 0.012 -7.69%
24-05-15 0.013 +18.18%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 03:45 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC7JB0
ISINDE000HC7JB07
Date issued 2023-06-21
Strike 80
Maturity 2025-06-18 (393 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.21
Lowest since issue 0.005

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.6 EUR
Average target price
39.84 EUR
Spread / Average Target
+0.61%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW